(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-14 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 1071695
| Date | Daily Closing Price | Open | High | Low | Volume |
| 14 Fri Mar 2025 | 3.30 | 3.34 | 3.41 | 3.29 | 0.66 times |
| 13 Thu Mar 2025 | 3.32 | 3.20 | 3.51 | 3.17 | 1.228 times |
| 12 Wed Mar 2025 | 3.19 | 3.06 | 3.20 | 3.02 | 0.733 times |
| 11 Tue Mar 2025 | 3.06 | 3.12 | 3.18 | 3.02 | 0.751 times |
| 10 Mon Mar 2025 | 3.11 | 3.29 | 3.32 | 3.09 | 0.98 times |
| 07 Fri Mar 2025 | 3.31 | 3.42 | 3.42 | 3.26 | 1.112 times |
| 06 Thu Mar 2025 | 3.37 | 3.41 | 3.55 | 3.37 | 1.226 times |
| 05 Wed Mar 2025 | 3.46 | 3.39 | 3.48 | 3.32 | 0.796 times |
| 04 Tue Mar 2025 | 3.39 | 3.40 | 3.57 | 3.35 | 1.015 times |
| 03 Mon Mar 2025 | 3.42 | 3.43 | 3.52 | 3.38 | 1.223 times |
My analysis of stock is bearish for shortterm, and stock might move down till 3.2 or till 3.1. Use a stoploss of 3.34 and if the stock hits stoploss, then it can shoot up till 3.45
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 3.02 |
| Downside Target | 3.11 |
| Downside Target | 3.24 |
| Upside Target | 3.39 |
| Upside Target | 3.47 |
| Upside Target | 3.54 |
| Upside Target | 3.57 |
| Upside Target | 3.70 |
| Upside Target | 3.79 |
| Upside Target | 3.99 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 3.04 |
| Downside Intraday Target | 2.79 |
| Upside Intraday Target | 3.53 |
| Upside Intraday Target | 3.77 |
| Downside Intraday Target | 3.28 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 14 Fri Mar 2025 | 3.30 | 3.29 | 3.51 | 3.02 | 0.81 times |
| 07 Fri Mar 2025 | 3.31 | 3.43 | 3.57 | 3.26 | 0.73 times |
| 28 Fri Feb 2025 | 3.45 | 3.42 | 3.70 | 3.27 | 2.528 times |
| 21 Fri Feb 2025 | 3.42 | 3.31 | 3.52 | 3.30 | 1.561 times |
| 14 Fri Feb 2025 | 3.29 | 3.44 | 3.47 | 3.24 | 0.453 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 14 Fri Mar 2025 | 3.30 | 3.43 | 3.57 | 3.02 | 0.598 times |
| 28 Fri Feb 2025 | 3.45 | 3.28 | 3.70 | 3.17 | 1.112 times |
| 31 Fri Jan 2025 | 3.33 | 3.30 | 3.54 | 3.13 | 1.192 times |
| 31 Tue Dec 2024 | 3.27 | 3.69 | 3.79 | 3.11 | 0.702 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.3 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.3 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.